Basel Medical Group Ltd BMGL
3.70
(0.10)
(2.63%)
as of 25 Sep
- Market cap
- $6.0M
- P/E
- —
Follow BMGL
| Dec '25 | Jun '25 | Dec '24 | Jun '24 | |
|---|---|---|---|---|
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.00 | — | — | — |
Free Cash Flow |
(5.77) | — | — | — |
Capital Expenditures |
(0.16) | — | — | — |
Piotroski F-Score |
0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||
Cash ROIC |
(42.95%) | 0.00% | 0.00% | 0.00% |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.00 | — | — | — |
Depreciation/Fixed assets |
1.08 | 0.00 | 0.00 | 0.00 |
Capex/Depreciation |
(0.59) | — | — | — |
Operating CF per Share |
0.00 | — | — | — |
Capex per Share |
0.00 | — | — | — |
Capex to Sales |
0.00 | — | — | — |
Columns are period end dates